CardioVista AI-assisted Cardiac Ultrasound Guidance and Analysis System

Laboratory Data Management / Analysis

Information

MicroPort Prophecy’s CardioVista AI-assisted Cardiac Ultrasound Guidance and Analysis System is a promising clinical solution designed to support inexperienced medical professionals in acquiring cardiac ultrasound images and automatically estimating left ventricular ejection fraction (LVEF) in point-of-care settings. The system leverages artificial intelligence to guide users in acquiring cardiac ultrasound images in eight specific echocardiographic views, including PLAX-LV, PSAX-AV, PSAX-MV, PSAX-PM, PSAX-Apex, A4C, A2C and A3C. It also automates the process of estimating LVEF based on the acquired A4C and A2C images. CardioVista is now in the process of pursuing class III premarket approval in China. A prospective multi-center clinical study is underway to evaluate the software's performance. The combination of AI-assisted comprehensive echocardiographic view acquisition and automated LVEF estimation has the potential to contribute to improved patient outcomes and a more streamlined cardiac ultrasound process for healthcare professionals.
MicroPort Scientific CorporationZ5.B19At MicroPort®, we are committed to enhancing the quality of human life by leveraging innovative science. We constantly strive to develop cutting-edge technologies in partnership with healthcare professionals and organizations to extend and transform the lives of patients. At MicroPort®, innovation is at the core of everything we do, including the treatments and services we develop, as well as the way we cultivate innovation. MicroPort® is a consortium of subsidiaries that work closely together, sharing resources and expertise while maintaining their independence and agility to drive innovation forward. Today, MicroPort® is focused on providing solutions in 12 major areas, which include Cardiovascular Intervention & Structural Heart Diseases, Electrophysiology & Cardiac Rhythm Management, Orthopedics & Soft Tissue Repair, Aortic & Peripheral Vascular Diseases, Neurovascular Intervention & Neuro-Modulation, Surgical and Critical Care & Intelligent Surgical Robotics, Endocrine Management & In Vitro Fertilization, Urology & Gynecology & Respiratory & Gastroenterology, Ophthalmology, ENT, Dental & Full Body Aesthetics, In vitro Diagnostics & Medical Imaging, Solid Tumor Treatment Technologies, Sleep Disorder, Depression & Rehabilitation. At MicroPort®, we strongly believe that every individual deserves access to top-notch healthcare and the opportunity to lead longer, healthier lives. This conviction motivates us to forge partnerships and collaborate with physicians and medical organizations to promote groundbreaking innovation in medical treatment.

Join the event!